VBI Vaccines Q2 EPS $(2.17) Misses $(2.16) Estimate, Sales $720.00K Miss $930.00K Estimate
Portfolio Pulse from Happy Mohamed
VBI Vaccines reported Q2 losses of $(2.17) per share, missing the analyst consensus estimate of $(2.16) by 0.46 percent. This is a 19.63 percent increase over losses from the same period last year. The company also reported quarterly sales of $720.00 thousand, missing the analyst consensus estimate of $930.00 thousand by 22.58 percent. This is a 108.09 percent increase over sales from the same period last year.
August 14, 2023 | 12:26 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
VBI Vaccines reported higher than expected losses and lower than expected sales for Q2. This could negatively impact the company's stock price in the short term.
VBI Vaccines reported higher than expected losses and lower than expected sales for Q2. This indicates that the company's financial performance was not as strong as analysts expected, which could lead to a decrease in the company's stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100